References
- Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurology. 2007 Feb; 6(2):182-7. PubMed | Google Scholar
- Feigin VL, Lawes CM, Bennett DA et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurology. 2009 Apr; 8(4):355-69. PubMed | Google Scholar
- Engels T, Baglione Q, Audibert M, Viallefont A, Mourji F, El Alaoui Faris M. GRAVCM Study Group Socioeconomic status and stroke prevalence in Morocco: results from the Rabat-Casablanca study. PLoS One. 2014 Feb 28; 9(2):e89271. PubMed | Google Scholar
- Ghandehari K. Barriers of Thrombolysis therapy in developing Countries. Stroke Research and Treatment. 2011; Volume 2011 (Article ID 686797): 4 pages. PubMed | Google Scholar
- Belkouch A, Jidane S, Chouaib N, Elbouti A, Nebhani T, Sirbou R, Bakkali H, Belyamani L. Thrombolysis for acute ischemic stroke by tenecteplase in the emergency department of a Moroccan hospital. The Pan African Medical Journal. 2015; 21:37. PubMed | Google Scholar
- Adams Jr HP and al. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke A Statement for Healthcare Professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1996 Sep 1; 94(5):1167-74. PubMed | Google Scholar
- Barber PA, Demchuk AM, Zhang J, Buchan AM. For the ASPECTS Study Group: validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy; Alberta Stroke Program Early CT Score. Lancet. 2000 May; 355 (9216):1670-74. PubMed | Google Scholar
- Bluhmki E, Chamorro A, Dávalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009 Dec;8(12):1095-102. PubMed | Google Scholar
- Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007 Jan 27; 369(9558):275-82. PubMed | Google Scholar
- Niaz A, Lars K, Kennedy RL, Robert M, Turgut T,
Danilo T. For the SITS Investigators Results of Intravenous
Thrombolysis Within 4.5 to 6 Hours and Updated Results
Within 3 to 4.5 Hours of Onset
of Acute Ischemic Stroke Recorded in the Safe Implementation
of Treatment in Stroke International Stroke Thrombolysis
Register (SITS-ISTR): An observational study. JAMA
Neurology. 2013 Jul;70(7):837-44. PubMed | Google
Scholar
- National Institute of Neurological Disorders and Stroke rt-PA StrokeStudy Group. Tissue plasminogen activator for acute ischemic stroke. NEngl J Med.1995; 333: 1581-87. PubMed | Google Scholar
- Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke. 2003 Dec; 34 (12):2847-50. PubMed | Google Scholar
- Hacke W, Donnan G, Fieschi C et al. Association of outcome with early strok treatment: pooled analysis of ATLANTIS , ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363:768-774. PubMed | Google Scholar
- Wardlaw JM, Murray V, Berge E et al. Thromobolysis for acute ischemic stroke. Cochrane Database Syst Rev. 2009 Oct 7;4: CD000213. PubMed | Google Scholar